Skip to main content

Table 2 Treatment substances administered to horses of the three treatment groups on days 1, 22 and 78

From: Local and systemic effect of transfection-reagent formulated DNA vectors on equine melanoma

Vaccine component Dose per injection
  Group eqIL12/18 Group hgp100 Group htyr
MIDGE-Th1 200 μg 200 μg 200 μg
eqIL12
MIDGE-Th1 200 μg 200 μg 200 μg
eqILRAPIL18
MIDGE-Th1 - 500 μg -
hgp100
MIDGE-Th1 - - 500 μg
htyr
SAINT 18 0.35 μmol 0.675 μmol 0.675 μmol